William R Timken insider trades: Regen Biologics (RGBO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 16, 2009 | RGBO | ↑ Buy | 17,143 | $3.50 | $60K | by Timken Living Trust | Jan 21, 2009 (5d) |
| Jul 29, 2008 | RGBI | ↑ Buy | 10,000 | $0.09 | $900 | by Timken Living Trust | Jul 31, 2008 (2d) |
| Nov 30, 2006 | RGBI | ↑ Buy | 270,270 | $0.37 | $100K | By Timken Living Trust | Dec 4, 2006 (4d) |
| Jul 14, 2005 | RGBI | ↑ Buy | 58,824 | $0.85 | $50K | By Timken Living Trust | Jul 18, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About William R Timken's insider trades
William R Timken is a director at Regen Biologics (RGBO). Since Jul 14, 2005, William has reported 4 open-market purchases worth $211K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (6 filings), grants and awards (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RGBO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.